Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

First report on the use of a thinner (125)I radioactive seed within 20-gauge needles for permanent radioactive seed prostate brachytherapy: evaluation of postimplant dosimetry and acute toxicity.

Sylvester J, Grimm P, Naidoo D, Bilik J, Miller A, Wong J.

Brachytherapy. 2013 Jul-Aug;12(4):375-81. doi: 10.1016/j.brachy.2012.07.002. Epub 2013 Feb 13.

PMID:
23415047
[PubMed - indexed for MEDLINE]
2.

Decline in urinary retention incidence in 805 patients after prostate brachytherapy: the effect of learning curve?

Keyes M, Schellenberg D, Moravan V, McKenzie M, Agranovich A, Pickles T, Wu J, Liu M, Bucci J, Morris WJ.

Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):825-34.

PMID:
16458775
[PubMed - indexed for MEDLINE]
3.

Comparison between high and low source activity seeds for I-125 permanent seed prostate brachytherapy.

Masucci GL, Donath D, T├ętreault-Laflamme A, Carrier JF, Hervieux Y, Larouche RX, Bahary JP, Taussky D.

Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):781-6. doi: 10.1016/j.ijrobp.2009.08.057. Epub 2010 Feb 19.

PMID:
20171808
[PubMed - indexed for MEDLINE]
4.

Iodine-125 brachytherapy for localized prostate cancer and urinary morbidity: a prospective comparison of two seed implant methods-preplanning and intraoperative planning.

Matzkin H, Kaver I, Stenger A, Agai R, Esna N, Chen J.

Urology. 2003 Sep;62(3):497-502.

PMID:
12946754
[PubMed - indexed for MEDLINE]
5.

Prostate implant dosimetric outcomes and migration patterns between bio-absorbable coated and uncoated brachytherapy seeds.

Sarkar A, Donavanik V, Zhang I, Chen H, Koprowski C, Hanlon A, Mourtada F, Strasser J, Raben A.

Brachytherapy. 2013 Jul-Aug;12(4):356-61. doi: 10.1016/j.brachy.2013.01.163. Epub 2013 Mar 7.

PMID:
23477885
[PubMed - indexed for MEDLINE]
6.

Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.

Raben A, Chen H, Grebler A, Geltzeiler J, Geltzeiler M, Keselman I, Litvin S, Sim S, Hanlon A, Yang J.

Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1631-8.

PMID:
15590195
[PubMed - indexed for MEDLINE]
7.

Factors predicting for postimplantation urinary retention after permanent prostate brachytherapy.

Lee N, Wuu CS, Brody R, Laguna JL, Katz AE, Bagiella E, Ennis RD.

Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1457-60.

PMID:
11121648
[PubMed - indexed for MEDLINE]
8.

Technical improvement in permanent seed implantation: a two-stage brachytherapy system. Description and comparison with current technique.

Grimm PD, Blasko JC, Sylvester JE, Heaney C, Gasparich J, Quackenbush J, Gottesman J, Downey J, Grier D, Roddy T, Nellans R, Sood N, Wahl D.

Brachytherapy. 2004;3(1):34-40.

PMID:
15110312
[PubMed - indexed for MEDLINE]
9.

Predictive factors of acute urinary morbidity after iodine-125 brachytherapy for localised prostate cancer: a phase 2 study.

Salem N, Simonian-Sauve M, Rosello R, Alzieu C, Gravis G, Maraninchi D, Bladou F.

Radiother Oncol. 2003 Feb;66(2):159-65.

PMID:
12648787
[PubMed - indexed for MEDLINE]
10.

Factors predicting for urinary morbidity following 125iodine transperineal prostate brachytherapy.

Williams SG, Millar JL, Duchesne GM, Dally MJ, Royce PL, Snow RM.

Radiother Oncol. 2004 Oct;73(1):33-8.

PMID:
15465143
[PubMed - indexed for MEDLINE]
11.

Correlation between pre- and postimplant dosimetry for iodine-125 seed implants for localized prostate cancer.

Al-Qaisieh B, Witteveen T, Carey B, Henry A, Bottomley D, Smith J, Franks K, Bownes P.

Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):626-30. doi: 10.1016/j.ijrobp.2009.04.002. Epub 2009 Jun 18.

PMID:
19540077
[PubMed - indexed for MEDLINE]
12.

Loose seeds vs. stranded seeds: a comparison of critical organ dosimetry and acute toxicity in (125)I permanent implant for low-risk prostate cancer.

Saibishkumar EP, Borg J, Yeung I, Cummins-Holder C, Landon A, Crook JM.

Brachytherapy. 2008 Apr-Jun;7(2):200-5. doi: 10.1016/j.brachy.2007.12.005. Epub 2008 Mar 24.

PMID:
18362087
[PubMed - indexed for MEDLINE]
13.

Predictive factors for acute and late urinary toxicity after permanent interstitial brachytherapy in Japanese patients.

Tanimoto R, Bekku K, Katayama N, Kobayashi Y, Ebara S, Araki M, Takemoto M, Yanai H, Nasu Y, Kumon H.

Int J Urol. 2013 Aug;20(8):812-7. doi: 10.1111/iju.12050. Epub 2013 Jan 8.

PMID:
23294011
[PubMed - indexed for MEDLINE]
14.

High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds.

Grills IS, Martinez AA, Hollander M, Huang R, Goldman K, Chen PY, Gustafson GS.

J Urol. 2004 Mar;171(3):1098-104.

PMID:
14767279
[PubMed - indexed for MEDLINE]
15.

Prostate brachytherapy seed migration and dosimetry: analysis of stranded sources and other potential predictive factors.

Fuller DB, Koziol JA, Feng AC.

Brachytherapy. 2004;3(1):10-9.

PMID:
15110308
[PubMed - indexed for MEDLINE]
16.

Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation.

Merrick GS, Butler WM, Dorsey AT, Lief JH.

Tech Urol. 2001 Sep;7(3):233-40.

PMID:
11575521
[PubMed - indexed for MEDLINE]
17.

Is there a role for postimplant dosimetry after real-time dynamic permanent prostate brachytherapy?

Potters L, Calugaru E, Jassal A, Presser J.

Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1014-9. Epub 2006 May 6.

PMID:
16682144
[PubMed - indexed for MEDLINE]
18.

A comparison of permanent prostate brachytherapy techniques: preplan vs. hybrid interactive planning with postimplant analysis.

Shanahan TG, Nanavati PJ, Mueller PW, Maxey RB.

Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):490-6.

PMID:
12023154
[PubMed - indexed for MEDLINE]
19.

Poor predictive value of intraoperative real-time dosimetry for prostate seed brachytherapy.

Igidbashian L, Donath D, Carrier JF, Lassalle S, Hervieux Y, David S, Bahary JP, Taussky D.

Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):605-9. doi: 10.1016/j.ijrobp.2008.06.1484.

PMID:
18793964
[PubMed - indexed for MEDLINE]
20.

A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy.

Potters L, Cao Y, Calugaru E, Torre T, Fearn P, Wang XH.

Int J Radiat Oncol Biol Phys. 2001 Jul 1;50(3):605-14.

PMID:
11395226
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk